Market Tracker

04/29 5:16pm ET

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

9.51
Delayed Data
As of Apr 29
 +0.19 / +2.04%
Today’s Change
7.86
Today|||52-Week Range
25.56
-35.92%
Year-to-Date
No recent news for Momenta Pharmaceuticals Inc.

Today’s Trading

Previous close9.32
Today’s open9.25
Day’s range9.22 - 9.64
Volume609,105
Average volume (3 months)694,797
Market cap$660.9M
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+30.89%
Earnings growth (this year)+12.76%
Earnings growth (next 5 years)--
Revenue growth (last year)+71.58%
P/E ratioNM
Price/Sales10.45
Price/Book1.74

Competitors

 Today’s
change
Today’s
% change
ADAPAdaptimmune Therapeu...+0.24+2.54%
NKNantKwest Inc-0.30-3.49%
IMGNImmunoGen Inc-1.60-18.93%
FMIFoundation Medicine ...-0.59-3.57%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 3, 2016
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$89.7M
Annual profit (last year)-$83.3M
Net profit margin-92.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class II Director
Craig A. Wheeler
Chief Operating Officer
Matthew P. Ottmer
Corporate headquarters
Cambridge, Massachusetts

Forecasts